|4Jul 5, 4:32 PM ET

Harsch Mutya 4

4 · VYNE Therapeutics Inc. · Filed Jul 5, 2023

Insider Transaction Report

Form 4
Period: 2023-06-30
Harsch Mutya
CHIEF LEGAL OFFICER AND GC
Transactions
  • Tax Payment

    Common Stock

    2023-06-30$4.10/sh157$64425,750 total
Footnotes (1)
  • [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION